Healthcare: KPMG study : Clinical studies take too long to be approved in Romania

Tuesday, March 28, 2017

Clinical studies take too long to be approved in Romania, a study made by KPMG for the Romanian Association of International Drug Manufacturers (ARPIM) and Association of Companies that Coordinate Clinical Studies in Romania (ACCSCR) says, quoted by business-review.eu. In Romania it takes 25 weeks, three times more than the timeline set by EU regulations, KPMG’s Clinical studies in ...

Article accessible to subscribers only. Please login or subscribe.

More

Economic

Tuesday, March 28, 2017

Infrastructure: The important airports of Romania are close to the traffic limit and need massive investments for extension
Railway staff, affected by the migration of skilled labor to other activity sectors
EU backs Romania with 20 mln euro for water infrastructure upgrade project
Trade: Only 18 percent of Romanian internet users made online purchases in 2016
Healthcare: KPMG study : Clinical studies take too long to be approved in Romania
Romania's mortality from tuberculosis halved in the past 13 years
Oradea, the city boasting the best medical facilities
Agriculture : PRIA Agriculture conference: In 2016, a trade deficit of 600 million euro of food products
Farmers began sowing early cold-resistant crops
Real Estate: RE/MAX Romania brokers real estate deals worth EUR 100 mln in 2016
Analysis: Logistics and industrial space deliveries in Romania to hit post-crisis record this year